Decoding Inflammation: Predicting Sepsis in the ICU.

Area of Science:

• Critical Care Medicine
• Laboratory Hematology
• Biomarker Discovery

Background:

• Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
• Traditional clinical signs and current screening scores for sepsis lack sufficient accuracy.
• There is a critical need for reliable and accessible biomarkers for early sepsis detection.

Purpose of the Study:

• To evaluate the predictive capabilities of six inflammatory biomarkers for sepsis development in ICU patients.
• To assess the association of these biomarkers with sepsis-related outcomes, including mortality and organ dysfunction.
• To identify cost-effective biomarkers for sepsis diagnosis in resource-limited environments.

Main Methods:

• A prospective observational study was conducted in an ICU setting.
• Six biomarkers (CRP, RDW, NLR, MDW, MNV, MMV) from complete blood count (CBC) samples were analyzed.
• Demographic data, clinical progression, and severity scores (APACHE II, SOFA) were collected.

Main Results:

• Monocyte distribution width (MDW) demonstrated the highest area under the curve (AUC) of 0.932 for sepsis prediction.
• MDW, mean neutrophil volume (MNV), and mean monocyte volume (MMV) exhibited 100% specificity.
• MDW and MMV were significantly correlated with sepsis prediction, with MDW showing the highest specificity (86.84%) among the tested biomarkers.

Conclusions:

• Biomarkers derived from routine CBC tests, specifically MDW and MMV, show significant potential for early sepsis diagnosis.
• These accessible biomarkers can be valuable tools in resource-limited settings for improving sepsis detection.
• Further validation of MDW and MMV may enhance sepsis management protocols.